These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37096763)

  • 21. Prognostic value of human papillomavirus in anal squamous cell carcinoma.
    Ravenda PS; Magni E; Botteri E; Manzotti M; Barberis M; Vacirca D; Trovato CM; Dell'Acqua V; Leonardi MC; Sideri M; Fazio N; Zampino MG
    Cancer Chemother Pharmacol; 2014 Nov; 74(5):1033-8. PubMed ID: 25209946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current therapeutic strategies for anal squamous cell carcinoma in Japan.
    Takashima A; Shimada Y; Hamaguchi T; Ito Y; Masaki T; Yamaguchi S; Kondo Y; Saito N; Kato T; Ohue M; Higashino M; Moriya Y;
    Int J Clin Oncol; 2009 Oct; 14(5):416-20. PubMed ID: 19856049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
    Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
    Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
    Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
    Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
    Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
    Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
    Toh E; Wilson J; Sebag-Montefiore D; Botterill I
    Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
    Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
    Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
    Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and prognosis of anal squamous cell carcinoma: a retrospective audit of 144 patients from 11 cancer hospitals in southern China.
    Lu Y; Wang X; Li P; Zhang T; Zhou J; Ren Y; Ding Y; Peng H; Wei Q; You K; Ong JJ; Fairley CK; Grulich AE; Huang M; Gao Y; Zou H
    BMC Cancer; 2020 Jul; 20(1):679. PubMed ID: 32693779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemoradiotherapy for anal cancer: are we as good as we think?
    Martin D; Rödel C; Fokas E
    Strahlenther Onkol; 2019 May; 195(5):369-373. PubMed ID: 30937508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
    Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
    Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
    [No Abstract]   [Full Text] [Related]  

  • 32. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
    Klas JV; Rothenberger DA; Wong WD; Madoff RD
    Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma.
    Cabel L; Jeannot E; Bieche I; Vacher S; Callens C; Bazire L; Morel A; Bernard-Tessier A; Chemlali W; Schnitzler A; Lièvre A; Otz J; Minsat M; Vincent-Salomon A; Pierga JY; Buecher B; Mariani P; Proudhon C; Bidard FC; Cacheux W
    Clin Cancer Res; 2018 Nov; 24(22):5767-5771. PubMed ID: 30054279
    [No Abstract]   [Full Text] [Related]  

  • 34. Salvage Surgery for Locoregional Failure in Anal Squamous Cell Carcinoma.
    Guerra GR; Kong JC; Bernardi MP; Ramsay RG; Phillips WA; Warrier SK; Lynch AC; Ngan SY; Heriot AG
    Dis Colon Rectum; 2018 Feb; 61(2):179-186. PubMed ID: 29337772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
    Ajani JA; Wang X; Izzo JG; Crane CH; Eng C; Skibber JM; Das P; Rashid A
    Dig Dis Sci; 2010 Apr; 55(4):1098-105. PubMed ID: 19399614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anal Squamous Cell Carcinoma in Ulcerative Colitis: Can Pouches Withstand Traditional Treatment Protocols?
    Lightner AL; Vaidya P; McMichael J; Click B; Regueiro M; Steele SR; Hull TL
    Dis Colon Rectum; 2021 Sep; 64(9):1106-1111. PubMed ID: 33951686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
    James RD; Glynne-Jones R; Meadows HM; Cunningham D; Myint AS; Saunders MP; Maughan T; McDonald A; Essapen S; Leslie M; Falk S; Wilson C; Gollins S; Begum R; Ledermann J; Kadalayil L; Sebag-Montefiore D
    Lancet Oncol; 2013 May; 14(6):516-24. PubMed ID: 23578724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
    Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
    Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
    Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
    Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.